Coexpression of EGFR, pEGFR, VEGF, pVEGF, PTEN, pAKT, and p21 in colorectal cancer patients can have IHC variability between metastases and primary tumours and for EGFR-targeted therapies, p21 and VEGF appear reliably as predictive factors of response

A. Bardier; J. Golmard; J. Dômont; C. Genestie; J. Vaillant; J. Taieb; G. Auclerc; D. Khayat; F. Capron; J. Spano

doi:10.1200/jco.2008.26.15_suppl.22074

Coexpression of EGFR, pEGFR, VEGF, pVEGF, PTEN, pAKT, and p21 in colorectal cancer patients can have IHC variability between metastases and primary tumours and for EGFR-targeted therapies, p21 and VEGF appear reliably as predictive factors of response

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.22074 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 22074-22074 ◽

Cited By ~ 2

Author(s):

A. Bardier ◽

J. Golmard ◽

J. Dômont ◽

C. Genestie ◽

J. Vaillant ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Predictive Factors ◽

Targeted Therapies ◽

Colorectal Cancer Patients

Download Full-text

Proinflammatory cytokines as predictive factors for response to chemotherapy or mental disorders present in colorectal cancer patients

Annals of Oncology ◽

10.1093/annonc/mdz155.230 ◽

2019 ◽

Vol 30 ◽

pp. iv63-iv64

Author(s):

C. Burz ◽

A. Bojan ◽

L. Balacescu ◽

C. Lisencu ◽

E. Puscas ◽

...

Keyword(s):

Colorectal Cancer ◽

Mental Disorders ◽

Cancer Patients ◽

Proinflammatory Cytokines ◽

Predictive Factors ◽

Response To Chemotherapy ◽

Colorectal Cancer Patients

Download Full-text

Predictive factors of early relapse in UICC stage IâIII colorectal cancer patients after curative resection

Journal of Surgical Oncology ◽

10.1002/jso.21404 ◽

2009 ◽

Vol 100 (8) ◽

pp. 736-743 ◽

Cited By ~ 57

Author(s):

Hsiang-Lin Tsai ◽

Koung-Shing Chu ◽

Yu-Ho Huang ◽

Yu-Chung Su ◽

Jeng-Yih Wu ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Predictive Factors ◽

Curative Resection ◽

Uicc Stage ◽

Early Relapse ◽

Stage Ia ◽

Colorectal Cancer Patients

Download Full-text

Predictive factors of high comprehensive complication index in colorectal cancer patients using Enhanced Recovery After Surgery protocol: role as a safety net in early discharge

Annals of Surgical Treatment and Research ◽

10.4174/astr.2021.101.6.340 ◽

2021 ◽

Vol 101 (6) ◽

pp. 340

Author(s):

Hyeong Yong Jin ◽

Injae Hong ◽

Jung Hoon Bae ◽

Chul Seung Lee ◽

Seung Rim Han ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Predictive Factors ◽

Enhanced Recovery ◽

Enhanced Recovery After Surgery ◽

Early Discharge ◽

Safety Net ◽

Comprehensive Complication Index ◽

Colorectal Cancer Patients

Download Full-text

Molecular predictive factors for toxicity in colorectal cancer patients

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3706 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3706-3706

Author(s):

G. Tonini ◽

B. Vincenzi ◽

G. Perrone ◽

A. La Cesa ◽

C. Grilli ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Predictive Factors ◽

Colorectal Cancer Patients

Download Full-text

Predictive factors for the effect of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC phase III study 40983).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.3544 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 3544-3544 ◽

Cited By ~ 2

Author(s):

H. Sorbye ◽

M. Mauer ◽

T. Gruenberger ◽

B. Glimelius ◽

G. J. Poston ◽

...

Keyword(s):

Colorectal Cancer ◽

Liver Metastasis ◽

Cancer Patients ◽

Predictive Factors ◽

Phase Iii ◽

Phase Iii Study ◽

Colorectal Cancer Patients ◽

Resectable Liver Metastasis

Download Full-text

Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)

Annals of Surgery ◽

10.1097/sla.0000000000000419 ◽

2015 ◽

Vol 261 (1) ◽

pp. e28-e29 ◽

Cited By ~ 3

Author(s):

Lilian Schwarz ◽

Pierre Michel ◽

Michel Scotté

Keyword(s):

Colorectal Cancer ◽

Liver Metastasis ◽

Cancer Patients ◽

Predictive Factors ◽

Intergroup Trial ◽

Colorectal Cancer Patients ◽

Resectable Liver Metastasis

Download Full-text

Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV

Supportive Care in Cancer ◽

10.1007/s00520-012-1667-5 ◽

2012 ◽

Vol 21 (5) ◽

pp. 1313-1319 ◽

Cited By ~ 35

Author(s):

Bruno Vincenzi ◽

Anna Maria Frezza ◽

Gaia Schiavon ◽

Chiara Spoto ◽

Raffaele Addeo ◽

...

Keyword(s):

Colorectal Cancer ◽

Peripheral Neuropathy ◽

Cancer Patients ◽

Predictive Factors ◽

Colorectal Cancer Patients

Download Full-text

Inclusion of targeted therapies in the standard of care for metastatic colorectal cancer patients in a German cancer center: the more the better?!

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-014-1829-6 ◽

2014 ◽

Vol 141 (3) ◽

pp. 515-522 ◽

Cited By ~ 5

Author(s):

Markus Moehler ◽

Thomas Thomaidis ◽

Chourouk Zeifri ◽

Tareq Barhoom ◽

Jens Marquardt ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Targeted Therapies ◽

Standard Of Care ◽

Cancer Center ◽

Colorectal Cancer Patients

Download Full-text

Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)

Annals of Surgery ◽

10.1097/sla.0b013e3182456aa2 ◽

2012 ◽

Vol 255 (3) ◽

pp. 534-539 ◽

Cited By ~ 63

Author(s):

Halfdan Sorbye ◽

Murielle Mauer ◽

Thomas Gruenberger ◽

Bengt Glimelius ◽

Graeme J. Poston ◽

...

Keyword(s):

Colorectal Cancer ◽

Liver Metastasis ◽

Cancer Patients ◽

Predictive Factors ◽

Intergroup Trial ◽

Colorectal Cancer Patients ◽

Resectable Liver Metastasis

Download Full-text

451P Novel somatic genetic variants as predictors of resistance to EGFR-targeted therapies in metastatic colorectal cancer patients

Annals of Oncology ◽

10.1016/j.annonc.2020.08.562 ◽

2020 ◽

Vol 31 ◽

pp. S434

Author(s):

P. Riera ◽

B. Rodríguez-Santiago ◽

A. Lasa ◽

L. González-Quereda ◽

B. Martín ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Targeted Therapies ◽

Genetic Variants ◽

Colorectal Cancer Patients

Download Full-text

Coexpression of EGFR, pEGFR, VEGF, pVEGF, PTEN, pAKT, and p21 in colorectal cancer patients can have IHC variability between metastases and primary tumours and for EGFR-targeted therapies, p21 and VEGF appear reliably as predictive factors of response

Proinflammatory cytokines as predictive factors for response to chemotherapy or mental disorders present in colorectal cancer patients

Predictive factors of early relapse in UICC stage IâIII colorectal cancer patients after curative resection

Predictive factors of high comprehensive complication index in colorectal cancer patients using Enhanced Recovery After Surgery protocol: role as a safety net in early discharge

Molecular predictive factors for toxicity in colorectal cancer patients

Predictive factors for the effect of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC phase III study 40983).

Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)

Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV

Inclusion of targeted therapies in the standard of care for metastatic colorectal cancer patients in a German cancer center: the more the better?!

Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)

451P Novel somatic genetic variants as predictors of resistance to EGFR-targeted therapies in metastatic colorectal cancer patients

Predictive factors of early relapse in UICC stage IâIII colorectal cancer patients after curative resection